Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL7489155

O=S(=O)(O)C(F)(F)F.O=[N+]([O-])c1cc(F)cc(F)c1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA5A P35218 1/20 0.39
CA9 Q16790 1/20 0.39
MEN1 O00255 3/20 0.38
HTT P42858 3/20 0.38
KMT2A Q03164 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GALR3 O60755 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 1/20 0.37
GPR35 Q9HC97 2/20 0.37
HSD11B1 P28845 1/20 0.36
TSHR P16473 1/20 0.36
CYP3A4 P08684 1/20 0.36
ALDH1A1 P00352 3/20 0.35
HIF1A Q16665 2/20 0.35
TTR P02766 2/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1172437 0.82 CYP19A1 (0.55) CYP19A1MEN1HTTKMT2ASMN1; SMN2
SCHEMBL7203812 0.77 CYP19A1 (0.62) CYP19A1MEN1HTTKMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL28104000 0.76 GAA (0.44) CYP19A1CA1CA2CA5ACA9
Nitrobenzene SCHEMBL2888054 0.76 ALDH1A1 (0.61) CA1CA2CA5ACA9MEN1
Fluoride SCHEMBL27574861 0.75 CYP19A1 (0.59) CYP19A1MEN1HTTKMT2ASMN1; SMN2
Trifluoromethanesulfonic Acid SCHEMBL7090348 0.75 PTPN1 (0.34) CA1CA9
Trifluoromethanesulfonic Acid SCHEMBL28570941 0.74 CA1 (0.50) CA1CA2CA5ACA9KMT2A
SCHEMBL15542221 0.74 HTT (0.42) CYP19A1CA1CA2CA5ACA9
P-Nitrophenol SCHEMBL1324262 0.74 CA1 (0.50) CA1CA2CA5ACA9MEN1
Trifluoromethanesulfonic Acid SCHEMBL28703240 0.74 CA12 (0.59) CA1CA9L3MBTL1ALDH1A1TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0640077-B1 OXAZOLIDINONES CONTAINING A SUBSTITUTED DIAZINE MOIETY AND THEIR USE AS ANTIMICROBIALS UPJOHN CO (US) 2002-06-26 EP disclosed
EP-0730591-B1 ESTERS OF SUBSTITUTED-HYDROXYACETYL PIPERAZINE PHENYL OXAZOLIDINONES UPJOHN CO (US) 1999-07-14 EP disclosed
US-5700799-A MICROBIOCIDES FOR TREATING HUMAN OR ANIMAL DISEASES PHARMACIA & UPJOHN COMPANY (US) 1997-12-23 US disclosed
US-5652238-A WATER SOLUBILITY; ANTIMICROBIAL AGENTS EFFECTIVE AGAINST RESISTANT STAPHYLOCOCCI, ENTEROCOCCI, AND STREPTOCOCCI PHARMACIA & UPJOHN COMPANY (US) 1997-07-29 US disclosed
EP-0730591-A1 ESTERS OF SUBSTITUTED-HYDROXYACETYL PIPERAZINE PHENYL OXAZOLIDINONES PHARMACIA & UPJOHN COMPANY (US) 1996-09-11 EP disclosed
US-5547950-A FOR TREATING DRUG RESISTANT STAPHYLOCOCCUS AND STREPTOCOCCUS INFECTIONS THE UPJOHN COMPANY (US) 1996-08-20 US disclosed
WO-1995014684-A1 ESTERS OF SUBSTITUTED-HYDROXYACETYL PIPERAZINE PHENYL OXAZOLIDINONES THE UPJOHN COMPANY (US) 1995-06-01 WO disclosed
EP-0640077-A1 OXAZOLIDINONES CONTAINING A SUBSTITUTED DIAZINE MOIETY AND THEIR USE AS ANTIMICROBIALS PHARMACIA & UPJOHN COMPANY (US) 1995-03-01 EP disclosed
WO-1993023384-A1 OXAZOLIDINONES CONTAINING A SUBSTITUTED DIAZINE MOIETY AND THEIR USE AS ANTIMICROBIALS THE UPJOHN COMPANY (US) 1993-11-25 WO disclosed